Orio Therapeutics Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$117K
- Investors
-
4
Orio Therapeutics General Information
Description
Developer of regenerative drugs intended to treat myocardial infarction. The company's technology modifies therapeutic proteins to improve delivery through controlled localization, for enhanced efficacy and reduced dosage that reduces fibrosis and cellular death, and preserve cardiac function, enabling patients with myocardial infarction to give priority to initial use technology in the development of therapeutics.
Contact Information
Website
www.oriotx.comCorporate Office
- Route de l Ile-au-Bois 3
- 1870 Monthey
- Switzerland
Corporate Office
- Route de l Ile-au-Bois 3
- 1870 Monthey
- Switzerland
Orio Therapeutics Timeline
Orio Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC | 10-Sep-2024 | $117K | Completed | Pre-Clinical Trials | ||
| 5. Angel (individual) | 15-Apr-2024 | Completed | Pre-Clinical Trials | |||
| 4. Early Stage VC | 15-May-2024 | Completed | Startup | |||
| 3. Grant | 22-Aug-2023 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2023 | $107K | $107K | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2023 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Orio Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Orio Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Orio Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kickfund | Venture Capital | Minority | ||
| Venture Kick | Accelerator/Incubator | Minority | ||
| Fondation The Ark | Accelerator/Incubator | |||
| Monash University | University | Minority |
Orio Therapeutics FAQs
-
When was Orio Therapeutics founded?
Orio Therapeutics was founded in 2023.
-
Where is Orio Therapeutics headquartered?
Orio Therapeutics is headquartered in Monthey, Switzerland.
-
What is the size of Orio Therapeutics?
Orio Therapeutics has 3 total employees.
-
What industry is Orio Therapeutics in?
Orio Therapeutics’s primary industry is Drug Discovery.
-
Is Orio Therapeutics a private or public company?
Orio Therapeutics is a Private company.
-
What is Orio Therapeutics’s current revenue?
The current revenue for Orio Therapeutics is .
-
How much funding has Orio Therapeutics raised over time?
Orio Therapeutics has raised $772K.
-
Who are Orio Therapeutics’s investors?
Kickfund, Venture Kick, Fondation The Ark, and Monash University have invested in Orio Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
